AVTX vs CPT · P/E 0.0, rev $441.0K vs P/E 104, rev $7.1M
Avalo Therapeutics Inc (AVTX) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the AVTX and CPT stock pages for the full models.
Not investment advice.